HUP0400667A2 - Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására - Google Patents

Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására

Info

Publication number
HUP0400667A2
HUP0400667A2 HU0400667A HUP0400667A HUP0400667A2 HU P0400667 A2 HUP0400667 A2 HU P0400667A2 HU 0400667 A HU0400667 A HU 0400667A HU P0400667 A HUP0400667 A HU P0400667A HU P0400667 A2 HUP0400667 A2 HU P0400667A2
Authority
HU
Hungary
Prior art keywords
gly
phe
preparation
tyr
hematopoiesis
Prior art date
Application number
HU0400667A
Other languages
English (en)
Inventor
Itai Bab
Michael Chorev
Arye Shteyer
Andras Muhlrad
Nura Mansur
Olga Gurevitch
Zvi Greenberg
Sergio Rosini
Silvia Trasciatti
Mario Petrini
Original Assignee
Yissum Research Development Company Of The Hebrew University Of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem filed Critical Yissum Research Development Company Of The Hebrew University Of Jerusalem
Publication of HUP0400667A2 publication Critical patent/HUP0400667A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya egy 200-1000 D molekulatömegű oligopeptid, amely aTyr-Gly-Phe-Gly-Gly, Tyr-Gly-Phe-His-Gly, Gly-Phe-Gly-Gly és Met-Tyr-Gly-Phe Gly-Gly csoportból választott peptid 1. számú, 2. számú, 3.számú, illetve 4. számú szekvencia elnevezésű aminosavszekvenciájáttartalmazza, olyan gyógyszerkészítmény előállítására történőalkalmazása, amely a soksejtvonalas hemopoetikus őssejtek vagy asoksejtvonalas korai CD34 pozitív hemopoetikus őssejtek perifériásvérbe való mobilizációjának fokozására szolgál. A találmány tárgyatovábbá az oligopeptid olyan perifériás vér őssejt transzplantátumkészítésére történő alkalmazása, amely egy ezt igénylő betegkezelésére szolgál. Ó
HU0400667A 2001-07-29 2001-07-29 Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására HUP0400667A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2001/000700 WO2003011313A1 (en) 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematopoiesis

Publications (1)

Publication Number Publication Date
HUP0400667A2 true HUP0400667A2 (hu) 2004-12-28

Family

ID=11043077

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400667A HUP0400667A2 (hu) 2001-07-29 2001-07-29 Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására

Country Status (19)

Country Link
US (1) US20050004037A1 (hu)
EP (1) EP1414480A1 (hu)
JP (1) JP2004536876A (hu)
KR (1) KR20040044436A (hu)
CN (1) CN1310672C (hu)
AU (1) AU2001282436B8 (hu)
BR (1) BR0117087A (hu)
CA (1) CA2456092A1 (hu)
CZ (1) CZ2004300A3 (hu)
EE (1) EE200400062A (hu)
HR (1) HRP20040135A2 (hu)
HU (1) HUP0400667A2 (hu)
IL (1) IL160016A0 (hu)
IS (1) IS7129A (hu)
MX (1) MXPA04000858A (hu)
NO (1) NO20040378L (hu)
NZ (1) NZ530904A (hu)
SK (1) SK912004A3 (hu)
WO (1) WO2003011313A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532261A (zh) * 2010-12-29 2012-07-04 中国医学科学院药物研究所 骨重建激活剂-酪脯肽及其药物组合物和用途
CN106726672A (zh) * 2016-12-29 2017-05-31 陕西慧康生物科技有限责任公司 一种化妆品组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5461034A (en) * 1989-02-23 1995-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren
IL104954A (en) * 1993-03-04 2006-08-01 Yissum Res Dev Co Use of osteogenic oligopeptides in the preparation of pharmaceutical compositions for the treatment of bone diseases and some such novel oligopeptides, pharmaceutical compositions containing them and their preparation
EP0721780A3 (en) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for promoting platelet and/or leukocyte production
CN1163262C (zh) * 1999-04-01 2004-08-25 上海益众生物技术有限公司 成骨生长肽药物组合物及制备方法和应用

Also Published As

Publication number Publication date
US20050004037A1 (en) 2005-01-06
SK912004A3 (en) 2004-07-07
BR0117087A (pt) 2004-08-03
IL160016A0 (en) 2004-06-20
IS7129A (is) 2004-01-28
KR20040044436A (ko) 2004-05-28
HRP20040135A2 (en) 2005-02-28
AU2001282436B8 (en) 2008-05-01
EP1414480A1 (en) 2004-05-06
EE200400062A (et) 2004-06-15
CA2456092A1 (en) 2003-02-13
WO2003011313A1 (en) 2003-02-13
CZ2004300A3 (cs) 2005-03-16
JP2004536876A (ja) 2004-12-09
NO20040378L (no) 2004-03-26
CN1551779A (zh) 2004-12-01
MXPA04000858A (es) 2005-06-06
WO2003011313A8 (en) 2004-04-08
NZ530904A (en) 2005-09-30
CN1310672C (zh) 2007-04-18
AU2001282436B2 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
Shafer et al. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide.
EP1310558A3 (en) Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
DE60329201D1 (de) Substituierte wt1-peptide
HUP0300814A2 (hu) Peptidszelekciós módszer
HUP0302585A2 (hu) Egy egyén allergiás reakcióra való hajlamának csökkentésére képes tejsavbaktériumok
IL122754A0 (en) Cyclosporin derivatives their preparation and pharmaceutical compositions containing them
DE60119145D1 (de) Ein antigen und ein adjuvans-peptid enthaltende impfstoffzusammensetzung
HUP0102302A2 (hu) Heliomicint kódoló gén és alkalmazása
WO2001096527A3 (en) Peptides with physiological activity
HUP0400667A2 (hu) Hemopoézist stimuláló oszteogén növekedési oligopeptidek alkalmazása gyógyszerkészítmények előállítására
ATE212060T1 (de) Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen
JP2020519623A (ja) メトトレキサートとペプチドの結合体
ES2171563T3 (es) Nueva familia de inhibidores de proteasas, y otras sustancias de actividad biologica.
JP2008518622A5 (hu)
HUP0301396A2 (hu) Integrin inhibitor hatású peptid- és peptidutánzó konjugátumok, azokat tartalmazó implantátumok és alkalmazásuk
HUP9801680A2 (hu) Peptidek és ezeket tartalmazó gyógyászati készítmények autoimmun betegségek kezelésére
ATE371737T1 (de) Proteaseresistente flint-analoge
CA2701991A1 (fr) Peptides cycliques comprenant au moins un residu aza.beta.3 aminoacyle et leurs utilisations
HUP0000836A2 (hu) Kollagén II-re specifikus T-sejt epitópot tartalmazó peptidek
EP1602665A4 (en) PHYSIOLOGICAL ACTIVE PEPTIDES AND MEDICAMENTS CONTAINING THEM
WO2023109991A1 (en) Antimicrobial peptides derived from human ameloblastin protein, effective on microbial biofilms
HUP0104598A1 (hu) Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek
YU8104A (sh) Oligopeptidi osteogenog rasta kao stimulatori hematopoeze
TH126305B (th) อนุพันธุ์เพพไทด์ vapeehptllteaplnpk ที่มีการกระตุ้นทางชีวภาพ

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees